Ignite Creation Date:
2024-05-06 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05246033
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-02
First Post:
2022-02-09
Brief Title:
A Dose Escalation Trial Evaluating Safety Efficacy and Pharmacokinetics of Multiple Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children With Achondroplasia
Sponsor:
Ascendis Pharma AS
Organization:
Ascendis Pharma AS
Organization Data
Organization:
Ascendis Pharma AS
Class:
INDUSTRY
Study ID:
TCC-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ascendis Pharma AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None